Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, August 25-27
23 août 2021 16h00 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of...
PROCESSA PHARMACEUTICALS PROVIDES SHAREHOLDER UPDATE
25 févr. 2020 09h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing drugs to improve the survival and/or quality of...